Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Mary Keogh"'
Autor:
Sarah L Bell, Sébastien Jodoin, Tanvir N. Bush, Liz Crow, Siri H. Eriksen, Emma Geen, Mary Keogh, Rebecca Yeo
Publikováno v:
International Journal of Disability and Social Justice, Vol 4, Iss 2, Pp 48-70 (2024)
Health. Disability. Vulnerability. These words are often used when discussing the risks of climate disruption. These discussions warn of the potential for climate impacts to “undermine 50 years of gains in public health” (as stated by the Lancet
Externí odkaz:
https://doaj.org/article/15ea5b1c6a7743e586322a57c36dd6ab
Publikováno v:
BMJ Global Health, Vol 8, Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/3481d51f2f08420590e88de21d894564
Autor:
Tom Burke, Andrew Deffew, Owen Stafford, Caroline Docherty, Sandra Burke, Remco Mostert, Jos van Loon, Marco Lombardi, Marianne Vaughan, Robert Brickell, Mary Keogh, Wendy Mahon, David O'Halloran
Publikováno v:
Frontiers in Rehabilitation Sciences, Vol 3 (2022)
ObjectivesQuality of life (QoL) is a multi-dimensional phenomenon composed of core domains that are influenced by personal characteristics, values, and environmental contributions. There are eight core domains of QoL aligned with both the United Nati
Externí odkaz:
https://doaj.org/article/e988ac989e75404e847329beab9db23d
Autor:
Sébastien Jodoin, Alexis Buettgen, Nora Groce, Pratima Gurung, Carlos Kaiser, Maria Kett, Mary Keogh, Setareki S. Macanawai, Yolanda Muñoz, Ipul Powaseu, Michael Ashley Stein, Penelope J. S. Stein, Elham Youssefian
Publikováno v:
PLOS Climate. 2:e0000153
Autor:
Mary Keogh
Publikováno v:
Development. 60:70-73
Women with disabilities until now have remained on the periphery of social justice movements due to the invisibility of women with disabilities issues, the limitations of current contextual and situational analysis to reflect the intersectionality of
Autor:
Cassandra Pond, Houman Khalili, Annette Lee, Anthony Liew, Lisa dos Santos, Sharon X. Liang, J.S. Whyte, Tawfiqul Bhuiya, A.W. Menzin, Iuliana Shapira, Peter K. Gregersen, Mary Keogh, Ilya Korsunsky, J.L. Lovecchio, Janaki Parameswaran, Andrew Shih
Publikováno v:
Journal of Investigative Medicine
MicroRNAs have been established as key regulators of tumor gene expression and as prime biomarker candidates for clinical phenotypes in epithelial ovarian cancer (EOC). We analyzed the coexpression and regulatory structure of microRNAs and their co-l
Autor:
Daniel R. Budman, Iuliana Shapira, J.L. Lovecchio, C. Mason, Peter K. Gregersen, L. Dos Santos, Sharron Liang, Houman Khalili, Keith Sultan, J.S. Whyte, Annette Lee, Michaela Oswald, Tawfiqul Bhuiya, Mary Keogh, A.W. Menzin
Publikováno v:
British Journal of Cancer
Background: Securing a diagnosis of ovarian cancer and establishing means to predict outcomes to therapeutics remain formidable clinical challenges. Early diagnosis is particularly important since survival rates are markedly improved if tumour is det
Autor:
M Barginear, Annette Lee, Emanuela Taioli, Mary Keogh, Michaela Oswald, Iuliana Shapira, T Bradley, Daniel R. Budman, C. Mason
Publikováno v:
Cancer Research. 72:P5-10
Background: Black women with triple negative breast cancer have 46% lower survival rates; this may be due to differences in tumor biology. We analyzed presurgical plasma microRNA of white (W) and black (B) women with TNBC enrolled in the breast ovari
Autor:
Peter K. Gregersen, J. Parasmeswaran, C. Mason, Michaela Oswald, Mary Keogh, L. Dos Santos, J.L. Lovecchio, Annette Lee, I. Shapira, A.W. Menzin, Sharon X. Liang, T. Bhuiya, J.S. Whyte
Publikováno v:
Gynecologic Oncology. 137:110-111
Autor:
Lisa A. Dos Santos, Cassandra Pond, Annette Lee, Mary Keogh, Tawfiqul Bhuiya, Sharon X. Liang, Michaela Oswald, Anthony Liew, Meagan Fastuca, Peter K. Gregersen, Ilya Korsunsky, Jill Suzanne Whyte, C. Mason, Janaki Parameswaran, Andrew Menzin, John L. Lovecchio, Iuliana Shapira, Houman Khalili
Publikováno v:
Journal of Clinical Oncology. 34:e17070-e17070
e17070Background: MicroRNAs (miRNA) have been established as key regulators of tumor gene expression as well as prime biomarker candidates for clinical phenotypes. We analyzed the regulatory structure of miRNAs and their colocalized gene targets in E